Website review: DrugBank Homepage
iforsythe discovered this in Science/Tech
•2 reviews since May 9, 2007
science, cheminformatics
•drugbank.ca
People who like this website

- Dubhlainn
St Ann

- lighthouse44004
Ohio

- seafarer314
Jacksonville

- devbasu
Toronto

- argikon
Toronto

- fabdeenyc
Selden

- appleslices
St John's

- caile-girl
The Home of

- proximal2u
On A Boat To
StumbleUpon is the best way to discover great web sites, videos, photos, blogs and more - based on your interests.
Everything is submitted and rated by the community. Discover, share and review the best of the web!
Reviews of this website

iforsythe discovered 15 months ago- The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. The database contains nearly 4300 drug entries including >1,000 FDA-approved small molecule drugs, 113 FDA-approved biotech (protein/peptide) drugs, 62 nutraceuticals and >3,000 experimental drugs. Additionally, more than 6,000 protein (i.e. drug target) sequences are linked to these drug entries. Each DrugCard entry contains more than 80 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data. Please cite: Wishart DS et al., DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006 1;34

proximal2u rated 4 months ago- The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. The database contains nearly 4800 drug entries including >1,480 FDA-approved small molecule drugs, 128 FDA-approved biotech (protein/peptide) drugs, 71 nutraceuticals and >3,200 experimental drugs. Additionally, more than 2,500 non-redundant protein (i.e. drug target) sequences are linked to these FDA approved drug entries. Each DrugCard entry contains more than 100 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data. This project is supported by Genome Alberta & Genome Canada, a private, non-profit corporation whose mandate is to develop and implement a national strategy in genomics and proteomics research for the benefit of all Canadians. For this purpose, it has received $600 million in funding from the Canadian government. A nice resource for Medical Scientists and health professionals.